21 May 2009
Dynamics of mood and anxiety disorders in heart transplant recipients
R Pudlo, M Piegza, M Zakliczyński, M ZembalaAnn Transplant 2009; 14(1): 64-64 :: ID: 880434
Abstract
Background: Although many studies concerning psychic disorders after
cardiac transplantation have been conducted, analysis covering the dynamics of mood and anxiety changes still need to be carried out. Such analyses are useful to determine the periods of increased morbidity risk and to plan supportive actions.
Material/Methods: In a group of 36 heart transplant recipients weekly measurements of anxiety, depression and mania levels were taken by means of standard psychopathological scales. Measurements were continued for eight weeks. Obtained data were analysed with the use of variance analysis for repeated measurements, which enabled us to track the dynamics of disorders.
Results: We found that the mean number of points obtained in mania scale was the highest during the first fortnight after transplantation and there was a sharp drop in the third week. From the third until the eight week fluctuations were slight. Drops between the following weeks: first, third and fourth, and seventh and eighth are statistically significant. Mean number of points scored in depression scale was the highest in the first week after the procedure and was dropping until the seventh week. Drops between the following weeks: first, fifth and sixth, and seventh and eighth are statistically significant. Fluctuations of anxiety level in the first eight weeks after transplantation are not clear and drops (elevations) among weeks never achieve statistical significance.
Conclusions: The severity of mood disorders is the highest during the fortnight after transplantation, whereas fluctuations of anxiety level during the first eight weeks are statistically insignificant.
Keywords: Heart Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






